CytoDyn (CYDY) Capital Expenditures (2010 - 2022)
CytoDyn (CYDY) posted Capital Expenditures of $17000.0 for Q1 2022, up 240.0% on a QoQ basis from $5000.0 in Q4 2021, and down 26.09% year-over-year from $23000.0 in Q1 2021.
CytoDyn (CYDY) Capital Expenditures (2010 - 2022) Analysis & Trends
CytoDyn's Capital Expenditures history runs 13 years deep, the most recent figure standing at $17000.0 for Q1 2022.
- Quarterly Capital Expenditures fell 26.09% year-over-year to $17000.0 in Q1 2022, while the trailing twelve-month figure through Feb 2022 was $52000.0 (down 49.51% YoY) and the FY2021 annual result came in at $122000.0, up 197.56% from the prior year.
- Capital Expenditures was $17000.0 for Q1 2022 at CytoDyn, up from $5000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $59000.0 in Q3 2020 and bottomed at $920.0 in Q1 2019.
- A 5-year average of $15642.9 and a median of $13000.0 in 2019 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 2508.7% in 2020, while the deepest fall reached 86.85% in 2020.
- CytoDyn's Capital Expenditures stood at $2262.0 in 2018, then soared by 297.88% to $9000.0 in 2019, then jumped by 100.0% to $18000.0 in 2020, then sank by 72.22% to $5000.0 in 2021, then soared by 240.0% to $17000.0 in 2022.
- Business Quant data shows CYDY's Capital Expenditures at $17000.0 in Q1 2022, $5000.0 in Q4 2021, and $8000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2022 | 17,000.00 |
| Feb 28, 2022 | 17,000.00 |
| Nov 30, 2021 | 5,000.00 |
| Nov 30, 2021 | 5,000.00 |
| Aug 31, 2021 | 8,000.00 |
| Aug 31, 2021 | 8,000.00 |
| May 31, 2021 | 22,000.00 |
| May 31, 2021 | 22,000.00 |
| Feb 28, 2021 | 23,000.00 |
| Feb 28, 2021 | 23,000.00 |
| Nov 30, 2020 | 18,000.00 |
| Nov 30, 2020 | 18,000.00 |
| Aug 31, 2020 | 59,000.00 |
| Aug 31, 2020 | 59,000.00 |
| May 31, 2020 | 3,000.00 |
| May 31, 2020 | 3,000.00 |
| Feb 29, 2020 | 24,000.00 |
| Feb 29, 2020 | 24,000.00 |
| Nov 30, 2019 | 9,000.00 |
| Nov 30, 2019 | 9,000.00 |